{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:27:20Z","timestamp":1793950040642,"version":"4.8.0"},"reference-count":44,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Belfast Health and Social Care Trust","award":["J-2223-152"],"award-info":[{"award-number":["J-2223-152"]}],"id":[{"id":"https:\/\/ror.org\/02tdmfk69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100023392","name":"NIHR Barts Biomedical Research Centre, Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR303715"],"award-info":[{"award-number":["NIHR303715"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Intensive Care Society"],"published-print":{"date-parts":[[2026,11]]},"abstract":"\n Introduction:<\/jats:title>\n Relative adrenal insufficiency and inflammation are associated with increased mortality in cardiogenic shock. In other shock states such as sepsis, guidelines recommend the administration of corticosteroids.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n We conducted a pre-registered (CRD420251042819) systematic review and meta-analysis, searching MEDLINE, Embase and Cochrane Central on 21 June 2025. We included randomised controlled trials and observational studies of adult patients with cardiogenic shock which compared corticosteroids to placebo or usual care. The primary outcome was acute mortality.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Of 3242 studies screened, eight studies (four randomised controlled trials and four observational cohort studies) were included with three observational studies of clearly-defined cardiogenic shock included in the primary analysis. There was substantial clinical heterogeneity across included studies of populations, interventions and observed mortality. Observational studies suggested between 7% and 29% of patients with cardiogenic shock received systemic corticosteroids. There was no evidence of an effect on acute mortality in unadjusted analysis (Risk Ratio\u2009=\u20091.05, 95% CI 0.98\u20131.13,\n p<\/jats:italic>\n \u2009=\u20090.17), but there was high risk of residual confounding and a very low certainty of evidence. There was weak evidence of increased rates of hyperglycaemia and hospital-acquired infection, but this was defined heterogeneously and the certainty of evidence was very low.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Our conclusions are limited by low study numbers, heterogeneity and uncertainty. There is insufficient evidence to determine the effect of corticosteroid use on acute mortality in cardiogenic shock. Further high-quality research is needed to assess the effect of corticosteroids on mortality in patients with cardiogenic shock.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/17511437261483562","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:56:48Z","timestamp":1790139408000},"page":"451-460","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroid therapy in cardiogenic shock: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"27","author":[{"given":"Clarence","family":"Zwengunde","sequence":"first","affiliation":[{"name":"Critical Care & Perioperative Medicine Group, Queen Mary University London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"White","sequence":"additional","affiliation":[{"name":"Critical Care & Perioperative Medicine Group, Queen Mary University London, UK"},{"name":"City St. George\u2019s University London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donovan","family":"Campbell","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assad","family":"Lahlou","sequence":"additional","affiliation":[{"name":"Adult Critical Care Unit, St. Bartholomew\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Buckel","sequence":"additional","affiliation":[{"name":"Critical Care & Perioperative Medicine Group, Queen Mary University London, UK"},{"name":"Adult Critical Care Unit, St. Bartholomew\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5766-990X","authenticated-orcid":false,"given":"Peter J.","family":"McGuigan","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, UK"},{"name":"Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Proudfoot","sequence":"additional","affiliation":[{"name":"Critical Care & Perioperative Medicine Group, Queen Mary University London, UK"},{"name":"Adult Critical Care Unit, St. Bartholomew\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-8354","authenticated-orcid":false,"given":"Alex","family":"Warren","sequence":"additional","affiliation":[{"name":"Critical Care & Perioperative Medicine Group, Queen Mary University London, UK"},{"name":"Adult Critical Care Unit, St. Bartholomew\u2019s Hospital, London, UK"},{"name":"Intensive Care National Audit & Research Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Waksman R Pahuja M van Diepen S et al. Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: Scientific Expert Panel from the Shock Academic Research Consortium (SHARC). Circulation 2023; 148: 1113\u20131126. https:\/\/doi.org\/10.1161\/circulationaha.123.064527","DOI":"10.1161\/CIRCULATIONAHA.123.064527"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Warren A McCall P Proudfoot A et al. EPidemiology Of Cardiogenic sHock in Scotland (EPOCHS): A multicentre prospective observational study of the prevalence management and outcomes of cardiogenic shock in Scotland. J Intensive Care Soc 2024; 25: 147\u2013155. https:\/\/doi.org\/10.1177\/17511437231217877","DOI":"10.1177\/17511437231217877"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Berg DD Bohula EA van Diepen S et al. Epidemiology of shock in contemporary cardiac intensive care units. Circ Cardiovasc Qual Outcomes 2019; 12: e005618. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Tavazzi G Tricella G Colombo CNJ et al. Cardiogenic shock in general intensive care unit: a nationwide prospective analysis of epidemiology and outcome. Eur Heart J Acute Cardiovasc Care 2024; 13: zuae108. https:\/\/doi.org\/10.1093\/ehjacc\/zuae036.065","DOI":"10.1093\/ehjacc\/zuae036.065"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Cohen J Venkatesh B. Relative adrenal insufficiency in the intensive care population; background and critical appraisal of the evidence. Anaesth Intensive Care 2010; 38: 425\u2013436. https:\/\/doi.org\/10.1177\/0310057x1003800304","DOI":"10.1177\/0310057X1003800304"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Annane D Pastores SM Rochwerg B et al. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med 2017; 45: 2078\u20132088. https:\/\/doi.org\/10.1097\/CCM.0000000000002737","DOI":"10.1097\/CCM.0000000000002737"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Sprung CL Annane D Keh D et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111\u2013124. https:\/\/doi.org\/10.1056\/NEJMoa071366","DOI":"10.1056\/NEJMoa071366"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Annane D Renault A Brun-Buisson C et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 2018; 378: 809\u2013818. https:\/\/doi.org\/10.1056\/NEJMoa1705716","DOI":"10.1056\/NEJMoa1705716"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Venkatesh B Finfer S Cohen J et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018; 378: 797\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1705835","DOI":"10.1056\/NEJMoa1705835"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Tol MM Shekar K Barnett AG et al. A preliminary investigation into adrenal responsiveness and outcomes in patients with cardiogenic shock after acute myocardial infarction. J Crit Care 2014; 29: 470.e1\u2013470.e6. https:\/\/doi.org\/10.1016\/j.jcrc.2014.01.020","DOI":"10.1016\/j.jcrc.2014.01.020"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000710"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab670","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Hear J 2021; 42: ehab368.","journal-title":"Eur Hear J"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf192"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Heidenreich PA Bozkurt B Aguilar D. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e895. https:\/\/doi.org\/10.1161\/cir.0000000000001063","DOI":"10.1161\/CIR.0000000000001073"},{"key":"e_1_3_2_18_2","first-page":"306","article-title":"Inflammatory response by 48 h after admission and mortality in patients with acute myocardial infarction complicated by cardiogenic shock","volume":"12","author":"Kunkel JB","year":"2023","unstructured":"Kunkel JB, Josiassen J, Helgestad OKL, et al. Inflammatory response by 48 h after admission and mortality in patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2023; 12: 306\u2013314.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Jentzer JC Lawler PR van Diepen S et al. Systemic inflammatory response syndrome is associated with increased mortality across the pectrum of shock severity in cardiac intensive care patients. Circ Cardiovasc Qual Outcomes 2020; 13: e006956. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.120.006956","DOI":"10.1161\/CIRCOUTCOMES.120.006956"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Lamontagne F Rochwerg B Lytvyn L et al. Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ 2018; 362: k3284. https:\/\/doi.org\/10.1136\/bmj.k3284","DOI":"10.1136\/bmj.k3284"},{"key":"e_1_3_2_21_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_2_22_2","unstructured":"Wells GA Shea B O\u2019Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (2011 accessed 4 July 2023)."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36: 1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03","DOI":"10.18637\/jss.v036.i03"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Balshem H Helfand M Sch\u00fcnemann HJ et al. GRADE guidelines: 3. rating the quality of evidence. J Clin Epidemiol 2011; 64: 401\u2013406. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.015","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Masroor M Ansari MI Umair M et al. Steroids and myocardial infarction: Investigating safety and short-term mortality in critical post-myocardial infarction patients. Am J Med Sci 2024; 368: 40\u201347. https:\/\/doi.org\/10.1016\/j.amjms.2024.02.007","DOI":"10.1016\/j.amjms.2024.02.007"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"Haddad G Maslove DM Mbuagbaw L et al. Corticosteroids in cardiogenic shock: a retrospective analysis of the medical information mart for intensive care-IV database. Crit Care Explor 2025; 7: e1210. https:\/\/doi.org\/10.1097\/CCE.0000000000001210","DOI":"10.1097\/CCE.0000000000001210"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Gastanadui MG Heck C Hysolli M et al. Early corticosteroid use and clinical outcomes in patients with cardiogenic shock. J Am Coll Cardiol 2025; 85: 2618. https:\/\/doi.org\/10.1016\/s0735-1097(25)03102-x","DOI":"10.1016\/S0735-1097(25)03102-X"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Kawai H Izawa H Yanase M et al. Re-evaluation of intravenous steroid therapy for histologically confirmed fulminant myocarditis. Int J Cardiol 2025; 427: 133108. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133108","DOI":"10.1016\/j.ijcard.2025.133108"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","unstructured":"Mentzelopoulos SD Zakynthinos SG Tzoufi M et al. Vasopressin epinephrine and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009; 169: 15\u201324. https:\/\/doi.org\/10.1001\/archinternmed.2008.509","DOI":"10.1001\/archinternmed.2008.509"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","unstructured":"Mentzelopoulos SD Malachias S Chamos C et al. Vasopressin steroids and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA 2013; 310: 270\u2013279. https:\/\/doi.org\/10.1001\/jama.2013.7832","DOI":"10.1001\/jama.2013.7832"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","unstructured":"Donnino MW Andersen LW Berg KM et al. Corticosteroid therapy in refractory shock following cardiac arrest: a randomized double-blind placebo-controlled trial. Crit Care 2016; 20: 82. https:\/\/doi.org\/10.1186\/s13054-016-1257-x","DOI":"10.1186\/s13054-016-1257-x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Mentzelopoulos SD Pappa E Malachias S et al. Physiologic effects of stress dose corticosteroids in in-hospital cardiac arrest (CORTICA): a randomized clinical trial. Resusc Plus 2022; 10: 100252. https:\/\/doi.org\/10.1016\/j.resplu.2022.100252","DOI":"10.1016\/j.resplu.2022.100252"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","unstructured":"Buckel M Maclean P Knight JC et al. Extending the \u2018host response\u2019 paradigm from sepsis to cardiogenic shock: evidence limitations and opportunities. Crit Care 2023; 27: 460. https:\/\/doi.org\/10.1186\/s13054-023-04752-8","DOI":"10.1186\/s13054-023-04752-8"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","unstructured":"Jentzer JC Berg DD Chonde MD et al. Mixed cardiogenic-vasodilatory shock current insights and future directions. JACC Adv 2025; 4: 101432. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101432","DOI":"10.1016\/j.jacadv.2024.101432"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","unstructured":"Ammirati E Conti N Frea S et al. Rationale and study design of the international randomized control trial MYocarditis THerapy with Steroids: the MYTHS trial. Eur Heart J 2024; 45: ehae666.1239. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.1239","DOI":"10.1093\/eurheartj\/ehae666.1239"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","unstructured":"Shetelig C Limalanathan S Hoffmann P et al. Association of IL-8 with infarct size and clinical outcomes in patients with STEMI. J Am Coll Cardiol 2018; 72: 187\u2013198. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.053","DOI":"10.1016\/j.jacc.2018.04.053"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","unstructured":"Odeberg J Halling A Ringborn M et al. Markers of inflammation predicts long-term mortality in patients with acute coronary syndrome \u2013 a cohort study. BMC Cardiovasc Disord 2025; 25: 190. https:\/\/doi.org\/10.1186\/s12872-025-04608-9","DOI":"10.1186\/s12872-025-04608-9"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00148-6"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","unstructured":"Stub D Bernard S Duffy SJ et al. Post cardiac arrest syndrome: a review of therapeutic strategies. Circulation 2011; 123: 1428\u20131435. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.988725","DOI":"10.1161\/CIRCULATIONAHA.110.988725"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","unstructured":"Berg DD Singal S Palazzolo M et al. Modes of death in patients with cardiogenic shock in the cardiac intensive care unit: a report from the critical care cardiology trials network. J Card Fail 2024; 30: 728\u2013733. https:\/\/doi.org\/10.1016\/j.cardfail.2024.01.012","DOI":"10.1016\/j.cardfail.2024.01.012"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Lauridsen MD Josiassen J Schmidt M et al. Prognosis of myocardial infarction-related cardiogenic shock according to preadmission out-of-hospital cardiac arrest. Resuscitation 2021; 162: 135\u2013142. https:\/\/doi.org\/10.1016\/j.resuscitation.2021.02.034","DOI":"10.1016\/j.resuscitation.2021.02.034"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","unstructured":"Jentzer JC Chonde MD Dezfulian C. Myocardial dysfunction and shock after cardiac arrest. Biomed Res Int 2015; 2015: 314796. https:\/\/doi.org\/10.1155\/2015\/314796","DOI":"10.1155\/2015\/314796"},{"key":"e_1_3_2_44_2","unstructured":"Intensive Care National Audit and Research Centre. Intensive Care National Audit and Research Centre \u2014 Audit Programme https:\/\/www.icnarc.org\/wp-content\/uploads\/2025\/06\/Audit-information-sheet-June-2025.pdf (2025 accessed 30 January 2026)."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","unstructured":"Dessap AM Bagate F Delmas C et al. Low-dose corticosteroid therapy for cardiogenic shock in adults (COCCA): study protocol for a randomized controlled trial. Trials 2022; 23: 4. https:\/\/doi.org\/10.1186\/s13063-021-05947-6","DOI":"10.1186\/s13063-021-05947-6"}],"container-title":["Journal of the Intensive Care Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17511437261483562","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17511437261483562","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17511437261483562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:46:23Z","timestamp":1793947583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17511437261483562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/17511437261483562"],"URL":"https:\/\/doi.org\/10.1177\/17511437261483562","relation":{},"ISSN":["1751-1437","1751-1437"],"issn-type":[{"value":"1751-1437","type":"print"},{"value":"1751-1437","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}